Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04248023 · ClinicalTrials.gov registry record · NA

Screening and Management of Unhealthy Alcohol Use in Primary Care

A NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
13,680
Enrollment target
2
Study locations

NCT04248023: Completed NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Virginia Commonwealth University.

NCT04248023 is a NA study of Alcohol Use Disorder and Alcohol Drinking that has completed, run by Virginia Commonwealth University. The registered enrollment target is 13,680 participants, above the 254-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (5286% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04248023, a NA study of Alcohol Use Disorder and Alcohol Drinking, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
13,680 participants
Enrollment target
2
Study locations

Study Summary

Unhealthy alcohol use is the third leading preventable cause of death in the United States. Yet, primary care physicians do not, on average, screen for and address unhealthy alcohol use in their patient populations. By implementing practice changes to promote screening and treatment, patients stand to reduce unhealthy alcohol use and benefit from improved health outcomes. This project will provide a sample of Virginia primary care practices with a practice facilitator, practice specific resources, education on screening and counseling, and education on medication assisted therapy. The project will measure whether this change will improve screening rates and promote reduction of unhealthy alcohol use.

Primary Outcome

This outcome will evaluate the percent of patients who were screened in clinic or report screening for alcohol use (numerator = intervention patients sampled who received counseling/ denominator = intervention patients who did not receive counseling at 3 time points.)

Interventions

  • BEHAVIORAL Practice Facilitation

Study Locations (2)

Virginia

  • Virginia Ambulatory Care Outcomes Research Network - Richmond
  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 13,680 participants
Start Date 2020-07-15
Est. Completion 2023-05-31
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT04248023 record still lists

NCT04248023 is an interventional study that assigns participants to a tested intervention. Its 13,680 participants enrollment target places it among the larger protocols in the corpus, above the 254-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (5286% higher).

The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Practice Facilitation is the first listed.

NCT04248023 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT04248023 about?

NCT04248023 is a clinical study titled "Screening and Management of Unhealthy Alcohol Use in Primary Care". Unhealthy alcohol use is the third leading preventable cause of death in the United States. Yet, primary care physicians do not, on average, screen for and address unhealthy alcohol use in their patient populations. By implementing practice changes to promote screening and treatment, patients stand ...

What is the current status of trial NCT04248023?

This trial is currently completed. It is a NA study. The enrollment target is 13,680 participants. The study started on 2020-07-15. Estimated completion is 2023-05-31.

What conditions does trial NCT04248023 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcohol Abuse.

What interventions are being tested in trial NCT04248023?

The interventions under investigation include: Practice Facilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04248023?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04248023 being conducted?

This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04248023's enrollment target sits among peer trials

13,680 1st of 184 higher than 184 of 184 other Alcohol Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06058767 · 13,764 participants · NA

    Preschool Hearing Screening

  • NCT05141396 · 13,400 participants · NA

    Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04248023, the US trial registry maintained by the National Library of Medicine. NCT04248023 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.